TY - JOUR A1 - Wolff, Martin A1 - Schüler, Anja A1 - Gast, Klaus A1 - Seckler, Robert A1 - Evers, Andreas A1 - Pfeiffer-Marek, Stefania A1 - Kurz, Michael A1 - Nagel, Norbert A1 - Haack, Torsten A1 - Wagner, Michael A1 - Thalhammer, Anja T1 - Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains JF - Molecular pharmaceutics N2 - Dual glucagon-like peptide-1/glucagon receptor agonists have emerged as promising candidates for the treatment of diabetes and obesity. Issues of degradation sensitivity and rapid renal clearance are addressed, for example, by the conjugation of peptides to fatty acid chains, promoting reversible albumin binding. We use combined dynamic and static light scattering to directly measure the self-assembly of a set of dual peptide agonists based on the exendin-4 structure with varying fatty acid chain lengths in terms of apparent molecular mass and hydrodynamic radius (R-S). We use NMR spectroscopy to gain an insight into the molecular architecture of the assembly. We investigate conformational changes of the monomeric subunits resulting from peptide self-assembly and assembly stability as a function of the fatty acid chain length using circular dichroism and fluorescence spectroscopy. Our results demonstrate that self-assembly of the exendin-4-derived dual agonist peptides is essentially driven by hydrophobic interactions involving the conjugated acyl chains. The fatty acid chain length affects assembly equilibria and the assembly stability, although the peptide subunits in the assembly retain a dynamic secondary structure. The assembly architecture is characterized by juxtaposition of the fatty acyl side chains and a hydrophobic cluster of the peptide moiety. This cluster experiences local conformational changes in the assembly compared to the monomeric unit leading to a reduction in solvent exposure. The N-terminal half of the peptide and a C-terminal loop are not in contact with neighboring peptide subunits in the assemblies. Altogether, our study contributes to a thorough understanding of the association characteristics and the tendency toward self-assembly in response to lipidation. This is important not only to achieve the desired bioavailability but also with respect to the physical stability of peptide solutions. KW - dual GLP-1/glucagon receptor agonist KW - self-assembly KW - light scattering KW - molecular architecture KW - lipidation KW - exendin-4 Y1 - 2020 U6 - https://doi.org/10.1021/acs.molpharmaceut.9b01195 SN - 1543-8384 SN - 1543-8392 VL - 17 IS - 3 SP - 965 EP - 978 PB - American Chemical Society CY - Washington ER - TY - JOUR A1 - Wolff, Martin A1 - Schüler, Anja A1 - Gast, Klaus A1 - Seckler, Robert A1 - Evers, Andreas A1 - Pfeiffer-Marek, Stefania A1 - Kurz, Michael A1 - Nagel, Norbert A1 - Haack, Torsten A1 - Wagner, Michael A1 - Thalhammer, Anja T1 - Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains JF - Molecular pharmaceutics N2 - Dual glucagon-like peptide-1/glucagon receptor agonists have emerged as promising candidates for the treatment of diabetes and obesity. Issues of degradation sensitivity and rapid renal clearance are addressed, for example, by the conjugation of peptides to fatty acid chains, promoting reversible albumin binding. We use combined dynamic and static light scattering to directly measure the self-assembly of a set of dual peptide agonists based on the exendin-4 structure with varying fatty acid chain lengths in terms of apparent molecular mass and hydrodynamic radius (R-S). We use NMR spectroscopy to gain an insight into the molecular architecture of the assembly. We investigate conformational changes of the monomeric subunits resulting from peptide self-assembly and assembly stability as a function of the fatty acid chain length using circular dichroism and fluorescence spectroscopy. Our results demonstrate that self-assembly of the exendin-4-derived dual agonist peptides is essentially driven by hydrophobic interactions involving the conjugated acyl chains. The fatty acid chain length affects assembly equilibria and the assembly stability, although the peptide subunits in the assembly retain a dynamic secondary structure. The assembly architecture is characterized by juxtaposition of the fatty acyl side chains and a hydrophobic cluster of the peptide moiety. This cluster experiences local conformational changes in the assembly compared to the monomeric unit leading to a reduction in solvent exposure. The N-terminal half of the peptide and a C-terminal loop are not in contact with neighboring peptide subunits in the assemblies. Altogether, our study contributes to a thorough understanding of the association characteristics and the tendency toward self-assembly in response to lipidation. This is important not only to achieve the desired bioavailability but also with respect to the physical stability of peptide solutions. KW - dual GLP-1/glucagon receptor agonist KW - self-assembly KW - light scattering KW - molecular architecture KW - lipidation KW - exendin-4 Y1 - 2020 U6 - https://doi.org/10.1021/acs.molpharmaceut.9b01195 SN - 1543-8384 VL - 17 IS - 3 SP - 965 EP - 978 PB - American Chemical Society CY - Washington ER - TY - JOUR A1 - Cui, Huanhuan A1 - Schlesinger, Jenny A1 - Schoenhals, Sophia A1 - Toenjes, Martje A1 - Dunkel, Ilona A1 - Meierhofer, David A1 - Cano, Elena A1 - Schulz, Kerstin A1 - Berger, Michael F. A1 - Haack, Timm A1 - Abdelilah-Seyfried, Salim A1 - Bulyk, Martha L. A1 - Sauer, Sascha A1 - Sperling, Silke R. T1 - Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA JF - Nucleic acids research N2 - DPF3 (BAF45c) is a member of the BAF chromatin remodeling complex. Two isoforms have been described, namely DPF3a and DPF3b. The latter binds to acetylated and methylated lysine residues of histones. Here, we elaborate on the role of DPF3a and describe a novel pathway of cardiac gene transcription leading to pathological cardiac hypertrophy. Upon hypertrophic stimuli, casein kinase 2 phosphorylates DPF3a at serine 348. This initiates the interaction of DPF3a with the transcriptional repressors HEY, followed by the release of HEY from the DNA. Moreover, BRG1 is bound by DPF3a, and is thus recruited to HEY genomic targets upon interaction of the two components. Consequently, the transcription of downstream targets such as NPPA and GATA4 is initiated and pathological cardiac hypertrophy is established. In human, DPF3a is significantly up-regulated in hypertrophic hearts of patients with hypertrophic cardiomyopathy or aortic stenosis. Taken together, we show that activation of DPF3a upon hypertrophic stimuli switches cardiac fetal gene expression from being silenced by HEY to being activated by BRG1. Thus, we present a novel pathway for pathological cardiac hypertrophy, whose inhibition is a long-term therapeutic goal for the treatment of the course of heart failure. Y1 - 2016 U6 - https://doi.org/10.1093/nar/gkv1244 SN - 0305-1048 SN - 1362-4962 VL - 44 SP - 2538 EP - 2553 PB - Oxford Univ. Press CY - Oxford ER - TY - JOUR A1 - Schröder-Preikschat, Wolfgang A1 - Garnatz, Thomas A1 - Haack, Ute A1 - Sander, Michael T1 - Experience made with the design and development of a message-passing kernel for a dual-processor-node parallel computer Y1 - 1996 ER - TY - CHAP A1 - Wiesner, Melanie A1 - Barknowitz, Gitte A1 - Florian, Simone A1 - Haack, Michael A1 - Lehmann, Carsten A1 - Lippmann, Doris A1 - Mewis, Inga A1 - Schumacher, Fabian A1 - Brigelius-Flohé, Regina A1 - Schreiner, Monika A1 - Glatt, Hansruedi T1 - Pak Choi Fed to Mice: Formation of DNA Adducts and Influence on Xenobiotic-Metabolizing Enzymes T2 - NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY Y1 - 2015 SN - 0028-1298 SN - 1432-1912 VL - 388 SP - S68 EP - S68 PB - Springer CY - New York ER -